Arena Pharmaceuticals up 63% on Positive FDA Panel Vote
Arena Pharmaceuticals (NASDAQ: ARNA) is today's biggest gainer following the announcement that its Lorcaserin receives positive vote from FDA. Lorcaserin is used to treat overweight and obese individuals.
Jack Lief, Arena's President and Chief Executive Officer said: "The advisory committee's positive vote supports our belief in lorcaserin as a potential new treatment option for the medical management of overweight and obesity. We will continue to work with the FDA as the agency completes its review of the lorcaserin new drug application."
Arena Pharmaceuticals is currently trading at $5.99, a gain of $2.33 or 63.62%.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.